Disposals:
Halliburton (NYSE:HAL) Director Murry Gerber sold 44,590 shares of the stock in a transaction on Monday, September 20th. The shares were sold at an average price of $19.33, for a total value of $861,924.70. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Shares of NYSE HAL traded down $0.12 during midday trading
on Tuesday, reaching $19.48. 6,125,435 shares of the company’s stock traded
hands, compared to its average volume of 9,502,723. The company has a market
cap of $17.35 billion, a price-to-earnings ratio of 121.76 and a beta of 2.84.
The stock’s 50 day simple moving average is $20.08 and its 200-day simple
moving average is $21.54. The company has a quick ratio of 1.75, a current
ratio of 2.29 and a debt-to-equity ratio of 1.68. Halliburton has a one year
low of $10.60 and a one year high of $25.00. Read
more …
UnitedHealth Group Incorporated (NYSE:UNH) Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction dated Friday, September 17th. The stock was sold at an average price of $419.00, for a total value of $1,047,500.00. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
UNH traded down $0.36 on Tuesday, hitting $412.34. The
company had a trading volume of 2,382,123 shares, compared to its average
volume of 2,984,847. The company has a current ratio of 0.77, a quick ratio of
0.77 and a debt-to-equity ratio of 0.62. The firm has a market cap of $388.80
billion, a P/E ratio of 27.24, a PEG ratio of 1.62 and a beta of 0.77. The
company’s fifty day moving average price is $416.51 and its 200 day moving
average price is $400.62. UnitedHealth Group Incorporated has a 1 year low of
$289.64 and a 1 year high of $431.36. Read
more …
Bristol-Myers Squibb (NYSE:BMY) CEO Giovanni Caforio sold 25,000 shares of the firm’s stock in a transaction that occurred on Monday, September 20th. The shares were sold at an average price of $60.64, for a total value of $1,516,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website.
NYSE BMY traded down $0.18 during midday trading on
Wednesday, hitting $60.15. The company had a trading volume of 9,658,651
shares, compared to its average volume of 10,596,237. The company has a market
capitalization of $133.66 billion, a PE ratio of -26.57, a P/E/G ratio of 1.20
and a beta of 0.61. The company has a current ratio of 1.54, a quick ratio of
1.42 and a debt-to-equity ratio of 1.15. The firm has a 50-day moving average
price of $66.48 and a 200-day moving average price of $65.37. Bristol-Myers
Squibb has a twelve month low of $56.75 and a twelve month high of $69.75. Read
more …
Williams-Sonoma, Inc. (NYSE:WSM) insider Ryan Ross sold 2,700 shares of the stock in a transaction that occurred on Tuesday, September 21st. The shares were sold at an average price of $185.57, for a total transaction of $501,039.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website.
Ryan Ross also recently made the following trade(s):
On Wednesday, July 7th, Ryan Ross sold 2,400 shares of
Williams-Sonoma stock. The stock was sold at an average price of $165.00, for a
total value of $396,000.00.
On Friday, June 25th, Ryan Ross sold 5,600 shares of
Williams-Sonoma stock. The stock was sold at an average price of $160.42, for a
total value of $898,352.00.
Shares of WSM traded down $1.40 during midday trading on
Thursday, reaching $188.51. 534,455 shares of the stock were exchanged,
compared to its average volume of 1,203,200. Williams-Sonoma, Inc. has a twelve
month low of $85.30 and a twelve month high of $204.41. The company has a
market cap of $14.02 billion, a P/E ratio of 15.07, a PEG ratio of 1.15 and a
beta of 1.68. The stock’s 50 day simple moving average is $168.25 and its 200
day simple moving average is $167.40. Read
more …